Blue Path Capital Management, LLC Abbott Laboratories Transaction History
Blue Path Capital Management, LLC
- $133 Billion
- Q1 2024
A detailed history of Blue Path Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Blue Path Capital Management, LLC holds 3,915 shares of ABT stock, worth $410,174. This represents 0.34% of its overall portfolio holdings.
Number of Shares
3,915
Previous 3,313
18.17%
Holding current value
$410,174
Previous $379 Million
17.41%
% of portfolio
0.34%
Previous 0.32%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,111Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.19M-
Vanguard Group Inc Valley Forge, PA165MShares$17.3 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.9 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.8 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.83 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.35 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $183B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...